ÂÜÀòÂÒÂ×

Samantha Howell currently serves as the Biodermatology Lead at LEO Pharma, beginning in September 2023. Prior to this role, Samantha was the Brand Lead for the Inflammation Portfolio at Amgen from December 2019 to September 2023, where responsibilities included leading cross-functional teams, developing strategic plans, and managing pre-launch initiatives for new brands. Samantha's experience also encompasses a position as Senior Product Manager at Celgene from March 2015 to December 2019, extensive roles at Almirall from 2007 to 2015—including UK Senior Product Manager and a secondment as Global Product Manager in Barcelona—and earlier experience as a Medical Representative at sanofi-aventis from 2002 to 2006. Noteworthy contributions include innovative congress activities aimed at reducing carbon footprints and prioritizing greener partnerships in line with NHS goals.